
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPSzBleFZKSWFKV1FudmFURmV2b0hodWFVZHl6ejBic2picjZyNGo3MUl2OGZNYnBlSl93aEJBTlNwaVBFSUxKcDhhY1l0UlRwcWNBSU1VbGZKY3ZrLWZLQ1JLTUUwUG82ZUFHdnpOQnQxV2Y1SzR0Z2hWRkZGV2M0Zm9QSm1zYkdJOVFKN2Q0ZjFNX2dIdjVfRHVKeG1zem42ekNmLU5RYTNCVG5IaExGZjBtRFhxZHBOY1k0TA?oc=5" target="_blank">FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility</a>&nbsp;&nbsp;<font color="#6f6f6f">Applied Clinical Trials</font>

